16 results
10-Q
2024 Q1
NAMS
NewAmsterdam Pharma Company NV
8 May 24
Quarterly report
4:30pm
or comparable foreign regulatory authorities in order to commence a trial;
identify, recruit and train suitable clinical investigators;
reach agreement … in foreign jurisdictions, at each clinical trial site;
identify, recruit and enroll suitable patients to participate in a trial;
have a sufficient
10-K
2023 FY
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Annual report
8:00am
the FDA or comparable foreign regulatory authorities in order to commence a trial;
identify, recruit and train suitable clinical investigators;
reach … clinical trial site;
identify, recruit and enroll suitable patients to participate in a trial;
have a sufficient number of patients complete a trial
424B3
NAMS
NewAmsterdam Pharma Company NV
15 Aug 23
Prospectus supplement
4:52pm
, including failure to:
obtain allowance from the FDA or comparable foreign regulatory authorities in order to commence a trial;
identify, recruit … (“IRB”) approval, or comparable ethics committee (“EC”), approval in foreign jurisdictions, at each clinical trial site;
identify, recruit and enroll
POS AM
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
allowance from the FDA or comparable foreign regulatory authorities in order to commence a trial;
identify, recruit and train suitable clinical … ethics committee (“EC”), approval in foreign jurisdictions, at each clinical trial site;
identify, recruit and enroll suitable patients to participate
6-K
EX-99.2
NAMS
NewAmsterdam Pharma Company NV
7 Aug 23
Research and development expenses
7:24am
or comparable foreign regulatory authorities in order to commence a trial;
identify, recruit and train suitable clinical investigators;
reach … ”), approval in foreign jurisdictions, at each clinical trial site;
identify, recruit and enroll suitable patients to participate in a trial;
have
424B3
aau7xh6
8 Jun 23
Prospectus supplement
5:01pm
424B3
10h4so rvbakt6jg1q6
6 Jun 23
Prospectus supplement
4:20pm
424B3
bwt2751t
25 Apr 23
Prospectus supplement
8:14am
POS AM
z45kjjvvmigtqqmv
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
zfmscl
19 Dec 22
Registration statement (foreign)
6:22pm
424B3
tv6wwddpuhepcxwxnuk
18 Oct 22
Prospectus supplement
4:41pm
F-4/A
82tvt
13 Oct 22
Registration of securities (foreign) (amended)
5:18pm
F-4/A
rl8k fpun1fwt
3 Oct 22
Registration of securities (foreign) (amended)
5:12pm
F-4/A
th7 1dea4t
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
kuzswrg4ru0igqzd
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next